Ikeda 1998.

Methods	Allocation concealment: unclear. Blinding: no. Intention to treat: no. Methodological score: 10.
Participants	NAIVE PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS Arms: 14/15 Excluded: 1/0 Mean age : 52/57 % males: NDA % transfusion: NDA % drug abuse: NDA % cirrhosis: 100/100 Genotypes : G2 (100/100%) Disease duration: NDA
Interventions	Experimental: Alfa‐2a IFN 9 MU TIW x 6 mo Control: no intervention Follow‐up: 3 mo
Outcomes	‐ biochemical SR ‐ virologic ETR and SR ‐ incidence of hepatocellular carcinoma
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear